Call for Your FREE Evaluation (877) 503-1595

ENERGY DRINKS BEING INVESTIGATED BY THE FDA

Areas of Practice

Get a FREE Evaluation

By submitting this form you agree to be contacted by KirkendallDwyer.com affiliates and/or attorneys regarding your claim. You consent to KirkendallDwyer.com contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.

Call for your FREE consultation with a personal attorney: (877) 503-1595

FDA

ENERGY DRINKS BEING INVESTIGATED BY THE FDA

Energy drinks are now as popular and widely available as regular sodas, but they have seven times the amount of caffeine in them as a regular Coca-Cola.  The FDA is now investigating a young girl’s death, which is thought to be related to consumption of two Monster Energy Drinks.  In addition, there have been five…..

Posted in Product Liability,
Tagged FDA, Energy Drinks, Monster Energy,

UPDATE ON MENINGITIS OUTBREAK: NECC PROBLEMS

The compounding agency at the center of the meningitis outbreak that has so far killed 23 people and sickened almost 300, was found to have problems with contamination control back in 2006.  At that time, The Massachusetts Board of Registration in Pharmacy investigated the NECC and found that there was inadequate contamination control.  Also, they…..

Posted in Pharmaceutical and Medical Device News,
Tagged meningitis, FDA,

DANGERS OF SLEEPING PILLS: OLD AND NEW

If there is one drug that most people have been desperate enough to consider at one time or another, it is a sleep-aid.  25% of Americans report suffering from occassional sleep problems, while 10% report chronic sleep problems.  Sleep deprivation is a problem most of us face at one time or another, and its effect…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, Ambien, Halcion, Lunesta, Rozerem, Sleep Deprivation, Sleep Problems, Sleeping pills, Sonata,

SURGICAL STAPLER RECALLED BY FDA

Johnson and Johnson is facing another medical device recall, this time with surgical stapler devices used in the treatment of hemorrhoids.  More than 150,000 of these devices are being taken off the market by the FDA in a Class 1 recall, which is the most serious type. The following devices are subject to the recall:…..

Posted in Pharmaceutical and Medical Device News,
Tagged johnson and johnson, FDA, J&J, Recalled Medical Products,

NEW CHOLESTEROL DRUGS ON THE WAY?

The world’s top-selling drug.  The best-selling drug of all time.  With laurels like these being attached to a cholesterol-lowering drug that has now gone off-patent, it is no surprise that pharmaceutical companies are now in a race to introduce a new cholesterol-lowering drug to the world, and reap its benefits. Lipitor was pharmaceutical company Pfizer’s…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, Pfizer, cholesterol medication, LDL, PCSK9 inhibitors,

REAL CHANGE COMING TO GLAXOSMITHKLINE?

This year, pharmaceutical giant GlaxoSmithKline pled guilty to criminal charges and was fiend $3 billion for promoting its anti-depressants for unapproved uses and failing to report safety data about a top diabetes drug. Because these misdeeds sound almost void of any real wrongdoing, allow us to provide you with an example of GSK’s misbehavior so…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, GlaxoSmithKline, GSK,

LATEST FROM THE FDA REGARDING PRADAXA

After Pradaxa gained the infamous distinction of being the most deadly drug of 2011, the FDA vowed to investigate its safety further.  On November 2, the FDA released a Drug Safety Communication explaining that the bleeding rates associated with Pradaxa use are not any higher than with warfarin use. Pradaxa is the first alternative to…..

Posted in Pharmaceutical and Medical Device News,
Tagged Pradaxa, FDA, warfarin,

GENERIC LIPITOR FOUND TO CONTAIN GLASS PARTICLES

In late 2011, the blockbuster cholesterol-lowering drug Lipitor’s patent expired, opening the market up to generic manufacturers.  Over 8.7 million people are on statin-therapy, and now they would now have a much less expensive option available to them. But this week, Ranbaxy Pharmaceuticals, the company that had the exclusive rights to sell generic atorvastatin for…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, cholesterol drugs, Lipitor, Ranbaxy Pharmaceuticals,

Bed Rails: Do they really make us safer?

Whether they are used for children or for the elderly, the common conception of bed rails are that they keep the more fragile among us safe.  But is this actually the truth? Between 2003 and 2011, over 4,000 people had to be treated in hospital emergency rooms for bedrail accidents each year.  Over 150 people…..

Posted in Product Liability,
Tagged FDA, bed rails, Consumer Product Safety Commission, Hospital safety,

LEVAQUIN UPDATE

Johnson & Johnson has scored a victory in the Levaquin litigation it has been fighting.  A United States Court of Appeals ruled for the drug giant, reversing a $1.1 million punitive award that a jury had awarded to plaintiff John Schedin. The Court of Appeals states that there was no evidence that Johnson & Johnson…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, J & J, Johnson & Johson, Levaquin,